2026Q1
| Insider | Role (last 12 mo) | Shares held | Filed at |
|---|---|---|---|
| FBIO Acquisition, Inc. | — | 7,559,774 | Sep 22, 2016 |
| Opus Point Partners, LLC | — | 7,559,774 | Sep 22, 2016 |
| Opus Point Healthcare Innovations (Offshore) Fund Ltd. | — | 7,559,774 | Sep 22, 2016 |
| Rosenwald Lindsay A Md | CEO | 4,111,417 | Jan 3, 2025 |
| Elliott Associates, L.P. | — | 2,076,381 | Jun 26, 2012 |
| Exec date | Filing date | Insider | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jan 1, 2026 | Jan 5, 2026 | Klein Dov | Director | Neutral | 90.0 | +27,322 | 26.58% | ✗ | - |
| Jan 1, 2026 | Jan 5, 2026 | Harvey Jimmie | Director | Neutral | 90.0 | +27,322 | 22.89% | ✗ | - |
| Jan 1, 2026 | Jan 5, 2026 | Lorenz Kevin | Director | Neutral | 90.0 | +27,322 | 37.08% | ✗ | - |
| Jan 1, 2026 | Jan 5, 2026 | Hoenlein Malcolm | Director | Neutral | 90.0 | +27,322 | 30.90% | ✗ | - |
| Jan 1, 2026 | Jan 5, 2026 | LOBELL J JAY | Director | Neutral | 90.0 | +27,322 | 16.55% | ✗ | - |
| Oct 1, 2025 | Oct 2, 2025 | Jin David | CFO | Neutral | 60.0 | +2,711 | 0.22% | ✗ | - |
| May 29, 2025 | Jun 3, 2025 | Fortress Biotech, Inc. | 10% Owner | Sell | 15.0 | -6,222,249 | -100.00% | ✗ | $25.2M |
| Apr 1, 2025 | Apr 1, 2025 | Jin David | CFO | Neutral | 60.0 | +5,000 | 0.40% | ✗ | - |
| Feb 26, 2025 | Feb 27, 2025 | Fortress Biotech, Inc. | 10% Owner | Neutral | 60.0 | +18,500 | 0.30% | ✗ | - |
| Jan 1, 2025 | Jan 3, 2025 | LOBELL J JAY | Director | Neutral | 90.0 | +49,383 | 42.68% | ✗ | - |
| Jan 1, 2025 | Jan 3, 2025 | Klein Dov | Director | Neutral | 90.0 | +49,383 | 92.48% | ✗ | - |
| Jan 1, 2025 | Jan 3, 2025 | Lu Lucy | Director | Neutral | 90.0 | +49,383 | 415.33% | ✗ | - |
| Jan 1, 2025 | Jan 3, 2025 | Harvey Jimmie | Director | Neutral | 90.0 | +49,383 | 70.55% | ✗ | - |
| Jan 1, 2025 | Jan 3, 2025 | Lorenz Kevin | Director | Neutral | 90.0 | +49,383 | 203.19% | ✗ | - |
| Jan 1, 2025 | Jan 3, 2025 | Hoenlein Malcolm | Director | Neutral | 90.0 | +49,383 | 126.49% | ✗ | - |
| Dec 31, 2024 | Jan 3, 2025 | Fortress Biotech, Inc. | 10% Owner | Neutral | 90.0 | +2,468,215 | 66.07% | ✗ | - |
| Jan 1, 2025 | Jan 3, 2025 | WEISS MICHAEL S | Chair | Neutral | 90.0 | +454,153 | 33.72% | ✗ | - |
| Jan 1, 2025 | Jan 3, 2025 | ROSENWALD LINDSAY A MD | CEO | Neutral | 90.0 | +454,153 | 12.42% | ✗ | - |
| Dec 19, 2024 | Dec 23, 2024 | Jin David | CFO | Neutral | 90.0 | +1,000,000 | 415.12% | ✗ | - |
| Oct 1, 2024 | Oct 1, 2024 | Jin David | CFO | Neutral | 77.5 | +2,625 | 1.10% | ✗ | - |
| Sep 27, 2024 | Oct 1, 2024 | Fortress Biotech, Inc. | 10% Owner | Neutral | 82.5 | +146,341 | 4.08% | ✗ | - |
| Sep 23, 2024 | Sep 25, 2024 | ROSENWALD LINDSAY A MD | CEO | Buy | 100.0 | +763,359 | 26.38% | ✗ | $1.4M |
| Jul 11, 2024 | Jul 15, 2024 | ROSENWALD LINDSAY A MD | CEO | Buy | 83.8 | +5,000 | 4.08% | ✗ | $37.4K |
| Jul 10, 2024 | Jul 12, 2024 | Jin David | CFO | Buy | 90.0 | +500 | 100.00% | ✗ | $3.8K |
| Jul 9, 2024 | Jul 11, 2024 | ROSENWALD LINDSAY A MD | CEO | Buy | 83.8 | +5,000 | 4.26% | ✗ | $37K |
| Jul 8, 2024 | Jul 10, 2024 | ROSENWALD LINDSAY A MD | CEO | Buy | 83.8 | +5,000 | 4.44% | ✗ | $36.8K |
| Jun 28, 2024 | Jul 1, 2024 | ROSENWALD LINDSAY A MD | CEO | Buy | 68.8 | +20,000 | 0.70% | ✗ | $32.7K |
| Jun 27, 2024 | Jun 28, 2024 | Fortress Biotech, Inc. | 10% Owner | Neutral | 90.0 | +575,191 | 29.84% | ✗ | - |
| May 24, 2024 | Fortress Biotech, Inc. | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| May 16, 2024 | May 20, 2024 | ROSENWALD LINDSAY A MD | CEO | Buy | 61.3 | +10,000 | 0.35% | ✗ | $17.6K |
| May 20, 2024 | May 20, 2024 | Klein Dov | Director | Sell | 26.3 | -10,000 | -15.77% | ✗ | $18.9K |
| Apr 16, 2024 | Apr 17, 2024 | Fortress Biotech, Inc. | 10% Owner | Neutral | 90.0 | +413,507 | 13.19% | ✗ | - |
| Apr 1, 2024 | Apr 2, 2024 | Jin David | CFO | Neutral | 67.5 | +2,352 | 1.00% | ✗ | - |
| Mar 20, 2024 | Mar 22, 2024 | Fortress Biotech, Inc. | 10% Owner | Neutral | 90.0 | +193,905 | 10.19% | ✗ | - |
| Jan 5, 2024 | Jan 9, 2024 | ROSENWALD LINDSAY A MD | CEO | Buy | 82.5 | +50,000 | 1.78% | ✗ | $118.8K |
| Jan 1, 2024 | Jan 3, 2024 | Lu Lucy | Director | Neutral | 90.0 | +3,333 | 38.95% | ✗ | - |
| Jan 1, 2024 | Jan 3, 2024 | Lorenz Kevin | Director | Neutral | 90.0 | +3,333 | 15.40% | ✗ | - |
| Jan 1, 2024 | Jan 3, 2024 | LOBELL J JAY | Director | Neutral | 85.0 | +6,666 | 6.11% | ✗ | - |
| Jan 1, 2024 | Jan 3, 2024 | Klein Dov | Director | Neutral | 90.0 | +6,666 | 11.75% | ✗ | - |
| Jan 1, 2024 | Jan 3, 2024 | Hoenlein Malcolm | Director | Neutral | 85.0 | +3,333 | 9.33% | ✗ | - |
| Jan 1, 2024 | Jan 3, 2024 | Harvey Jimmie | Director | Neutral | 90.0 | +6,666 | 10.53% | ✗ | - |
| Jan 1, 2024 | Jan 3, 2024 | WEISS MICHAEL S | Officer | Neutral | 90.0 | +216,465 | 19.15% | ✗ | - |
| Jan 1, 2024 | Jan 3, 2024 | Rowinsky Eric K | Director | Neutral | 90.0 | +6,666 | 10.73% | ✗ | - |
| Jan 1, 2024 | Jan 3, 2024 | ROSENWALD LINDSAY A MD | CEO | Neutral | 85.0 | +216,465 | 8.33% | ✗ | - |
| Jan 2, 2024 | Jan 3, 2024 | Fortress Biotech, Inc. | 10% Owner | Neutral | 90.0 | +419,092 | 27.78% | ✗ | - |
| Dec 29, 2023 | Jan 3, 2024 | Fortress Biotech, Inc. | 10% Owner | Neutral | 85.0 | +158,134 | 9.07% | ✗ | - |
| Jan 2, 2024 | Jan 3, 2024 | Fortress Biotech, Inc. | 10% Owner | Neutral | 90.0 | +2,101,496 | 203.56% | ✗ | - |
| Dec 20, 2023 | Dec 22, 2023 | Jin David | CFO | Neutral | 90.0 | +140,000 | 145.96% | ✗ | - |
| Nov 14, 2023 | Nov 16, 2023 | ROSENWALD LINDSAY A MD | CEO | Buy | 100.0 | +1,567,515 | 152.20% | ✗ | $2.7M |
| Nov 14, 2023 | Nov 16, 2023 | WEISS MICHAEL S | Officer | Buy | 95.0 | +147,058 | 14.95% | ✗ | $250K |
| Sep 26, 2023 | Sep 27, 2023 | ROSENWALD LINDSAY A MD | CEO | Buy | 68.8 | +100,000 | 0.65% | ✗ | $28.3K |
| Sep 25, 2023 | Sep 26, 2023 | Fortress Biotech, Inc. | 10% Owner | Neutral | 82.5 | +80,906 | 4.86% | ✗ | - |
| Sep 8, 2023 | Sep 12, 2023 | Fortress Biotech, Inc. | 10% Owner | Buy | 97.5 | +418,410 | 68.15% | ✗ | $301.3K |
| Aug 17, 2023 | Aug 21, 2023 | ROSENWALD LINDSAY A MD | CEO | Buy | 95.0 | +20,000 | 21.62% | ✗ | $210.9K |
| Jun 30, 2023 | Jul 3, 2023 | Fortress Biotech, Inc. | 10% Owner | Neutral | 85.0 | +81,406 | 5.15% | ✗ | - |
| Mar 31, 2023 | Apr 4, 2023 | Fortress Biotech, Inc. | 10% Owner | Neutral | 85.0 | +52,419 | 9.33% | ✗ | - |
| Mar 31, 2023 | Apr 4, 2023 | Fortress Biotech, Inc. | 10% Owner | Neutral | 85.0 | +78,214 | 5.20% | ✗ | - |
| Feb 10, 2023 | Feb 14, 2023 | WEISS MICHAEL S | Officer | Buy | 92.5 | +1,197,604 | 8.84% | ✗ | $1000K |
| Feb 10, 2023 | Feb 14, 2023 | Rowinsky Eric K | Director | Buy | 77.5 | +11,976 | 1.30% | ✗ | $10K |
| Feb 10, 2023 | Feb 14, 2023 | ROSENWALD LINDSAY A MD | CEO | Buy | 100.0 | +2,395,209 | 18.49% | ✗ | $2M |
| Feb 10, 2023 | Feb 14, 2023 | Lu Lucy | Director | Buy | 85.0 | +11,976 | 9.86% | ✗ | $10K |
| Feb 10, 2023 | Feb 14, 2023 | LOBELL J JAY | Director | Buy | 95.0 | +299,401 | 22.41% | ✗ | $250K |
| Feb 10, 2023 | Feb 14, 2023 | Jin David | CFO | Buy | 83.8 | +35,928 | 2.56% | ✗ | $30K |
| Jan 6, 2023 | Jan 6, 2023 | Fortress Biotech, Inc. | 10% Owner | Neutral | 90.0 | +2,807,008 | 14.16% | ✗ | - |
| Jan 5, 2023 | Jan 6, 2023 | Fortress Biotech, Inc. | 10% Owner | Neutral | 90.0 | +368,907 | 32.51% | ✗ | - |
| Jun 1, 2022 | Jan 4, 2023 | ROSENWALD LINDSAY A MD | CEO | Neutral | 90.0 | +1,223,558 | 10.43% | ✗ | - |
| Jan 1, 2023 | Jan 4, 2023 | Lu Lucy | Director | Neutral | 90.0 | +50,000 | 70.03% | ✗ | - |
| Jan 1, 2023 | Jan 4, 2023 | WEISS MICHAEL S | Officer | Neutral | 85.0 | +1,219,294 | 9.88% | ✗ | - |
| Jan 1, 2023 | Jan 4, 2023 | Rowinsky Eric K | Director | Neutral | 90.0 | +100,000 | 12.20% | ✗ | - |
| Jan 1, 2023 | Jan 4, 2023 | Lorenz Kevin | Director | Neutral | 90.0 | +50,000 | 18.21% | ✗ | - |
| Jan 1, 2023 | Jan 4, 2023 | LOBELL J JAY | Director | Neutral | 85.0 | +100,000 | 8.09% | ✗ | - |
| Jan 1, 2023 | Jan 4, 2023 | Klein Dov | Director | Neutral | 90.0 | +100,000 | 13.32% | ✗ | - |
| Jan 1, 2023 | Jan 4, 2023 | Hoenlein Malcolm | Director | Neutral | 90.0 | +50,000 | 10.30% | ✗ | - |
| Jan 1, 2023 | Jan 4, 2023 | Harvey Jimmie | Director | Neutral | 90.0 | +100,000 | 11.76% | ✗ | - |
| Dec 31, 2022 | Jan 4, 2023 | Fortress Biotech, Inc. | 10% Owner | Neutral | 90.0 | +322,225 | 134.63% | ✗ | - |
| Dec 16, 2022 | Dec 19, 2022 | Lu Lucy | Director | Neutral | 90.0 | +30,000 | 72.46% | ✗ | - |
| Dec 19, 2022 | Lu Lucy | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Dec 1, 2022 | Dec 5, 2022 | ROSENWALD LINDSAY A MD | CEO | Buy | 72.5 | +100,000 | 0.86% | ✗ | $68K |
| Nov 30, 2022 | Dec 2, 2022 | ROSENWALD LINDSAY A MD | CEO | Buy | 47.5 | +5,000 | 0.04% | ✗ | $2.8K |
| Nov 30, 2022 | Dec 2, 2022 | Jin David | CFO | Buy | 60.0 | +5,000 | 0.36% | ✗ | $2.8K |
| Oct 26, 2022 | Oct 28, 2022 | Jin David | CFO | Neutral | 90.0 | +1,350,000 | 2822.56% | ✗ | - |
| Oct 21, 2022 | Oct 24, 2022 | ROSENWALD LINDSAY A MD | CEO | Buy | 72.5 | +100,000 | 0.87% | ✗ | $69.5K |
| Aug 25, 2022 | Jin David | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Aug 5, 2021 | Apr 29, 2022 | Klein Dov | Director | Sell | 91.3 | +96,015 | 14.66% | ✗ | $12.3K |
| Sep 21, 2021 | Apr 29, 2022 | Hunter Robyn | CFO | Sell | 42.5 | -28,292 | -14.72% | ✗ | $88.6K |
| Jan 1, 2022 | Apr 29, 2022 | WEISS MICHAEL S | Officer | Neutral | 85.0 | +1,102,986 | 9.82% | ✗ | - |
| Sep 30, 2021 | Apr 29, 2022 | Hoenlein Malcolm | Director | Neutral | 90.0 | +50,636 | 11.64% | ✗ | - |
| Jun 1, 2021 | Apr 29, 2022 | ROSENWALD LINDSAY A MD | CEO | Neutral | 90.0 | +1,118,285 | 10.75% | ✗ | - |
| Jan 1, 2022 | Apr 29, 2022 | Lorenz Kevin | Director | Neutral | 90.0 | +50,000 | 22.26% | ✗ | - |
| Jan 1, 2022 | Apr 29, 2022 | Harvey Jimmie | Director | Neutral | 90.0 | +100,000 | 13.33% | ✗ | - |
| Jan 1, 2022 | Apr 29, 2022 | LOBELL J JAY | Director | Neutral | 85.0 | +100,000 | 8.80% | ✗ | - |
| Jan 1, 2022 | Apr 29, 2022 | Rowinsky Eric K | Director | Neutral | 90.0 | +100,000 | 13.89% | ✗ | - |
| Jan 1, 2021 | Apr 9, 2021 | WEISS MICHAEL S | Officer | Neutral | 90.0 | +1,030,339 | 10.10% | ✗ | - |
| Jan 1, 2021 | Apr 9, 2021 | Rowinsky Eric K | Director | Sell | 95.0 | +70,000 | 10.77% | ✗ | $127.1K |
| Jun 1, 2020 | Apr 9, 2021 | ROSENWALD LINDSAY A MD | CEO | Neutral | 90.0 | +1,033,191 | 11.02% | ✗ | - |
| Jan 1, 2021 | Apr 9, 2021 | Lorenz Kevin | Director | Neutral | 90.0 | +50,000 | 30.38% | ✗ | - |
| Jan 1, 2021 | Apr 9, 2021 | LOBELL J JAY | Director | Neutral | 85.0 | +100,000 | 9.65% | ✗ | - |
| Jan 1, 2021 | Apr 9, 2021 | Klein Dov | Director | Neutral | 90.0 | +100,000 | 18.02% | ✗ | - |
| Jan 1, 2021 | Apr 9, 2021 | Hoenlein Malcolm | Director | Neutral | 90.0 | +50,000 | 12.99% | ✗ | - |
| Jan 1, 2021 | Apr 9, 2021 | Harvey Jimmie | Director | Neutral | 90.0 | +100,000 | 15.38% | ✗ | - |